https://www.selleckchem.com/products/h2dcfda.html
Although colorectal cancer (CRC) screening programs reduce CRC incidence and mortality, they are associated with risks in healthy subjects. However, the risk of overtreatment and overdiagnosis has not been determined yet. The aim of this study was to report the surgery rates in patients with nonmalignant lesions detected within the first round of a fecal immunochemical test (FIT) based CRC screening program and the factors associated with it. We included in this analysis all patients with nonmalignant lesions detected between May 2013 a
Like
Comment
Share
